Real-time enrollment status for this neurotrophic keratitis clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 8:15 AM UTC
| NCT Number | NCT05927428 |
| Recruiting Status | Recruiting |
| Condition | Neurotrophic Keratitis |
| Phase | PHASE2 |
| Target Enrollment | 12 participants |
| Active Locations | 1 sites in the US |
| Sponsor | BRIM Biotechnology Inc. |
| Last Updated on CT.gov | October 28, 2024 (Oct 28, 2024) |
As of July 17, 2026: Clinical trial NCT05927428 is currently recruiting participants. This phase2 study for neurotrophic keratitis is actively seeking new participants at 1 location across the United States. The study is sponsored by BRIM Biotechnology Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05927428 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05927428 was last updated Oct 28, 2024 (October 28, 2024). HelloStudys verifies this status automatically.